Dianthus achieved its NASDAQ listing last year via a merger with Magenta Therapeutics. The company is focused on development of a single drug candidate, DNTH-103, which targets the complement system, ...
10don MSN
Immune system plays a major role in brain damage after repeated concussions, study suggests
From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...
The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...
Medical University of South Carolina scientists have uncovered a link between the innate immune system and cognitive problems ...
Health on MSN
How rare is complement 3 glomerulopathy?
Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is considered a very rare disease. With C3G, patients have issues with their immune system that cause kidney damage and symptoms ...
C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) are two rare kidney diseases. They’re both driven by activity of the complement system, which is a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback